NEW YORK (GenomeWeb) — Early-stage molecular diagnostics developer Mesa Tech International has been awarded $1 million from the National Institutes of Health to further develop its low-cost nucleic acid testing device for respiratory disease diagnosis.
NEW YORK (GenomeWeb) – Cancer Genetics today said that it has received CLIA and New York State approvals to offer its mature B-cell neoplasm array for follicular lymphoma (MatBA-FL) and mantle-cell lymphoma (MatBA-MCL) as laboratory-developed tests.
NEW YORK (GenomeWeb News) – Med BioGene today said that its commercial partner, Precision Therapeutics, has been certified to perform Med BioGene's lung cancer test out of Precision's Pittsburgh laboratory.
NEW YORK (GenomeWeb News) – Metamark Genetics today announced that Massachusetts has licensed the company's laboratory as it prepares to launch its prognostic assay for managing patients with prostate cancer.
NEW YORK (GenomeWeb News) – Exact Sciences has finished the construction of its internal laboratory and received CLIA certification for it in the fourth quarter, the company said on its fourth quarter earnings conference call on Thursday.
NEW YORK (GenomeWeb News) – Natera today announced that New York has issued a permit for the company's CLIA laboratory, allowing Natera to offer its preconception and prenatal tests to expecting parents in the state.